Ewing’s U: Dr. Chandrika Behura NEW Clinical Trial | Ck2 Inhibitor for Solid Tumors

In this episode of Ewing’s U, Dr. Chandrika Behura (at Penn State Health Children's Hospital) discusses the research behind a new CK2 inhibitor for solid tumors (including Ewing sarcoma) and shares details about a new clinical trial (BCC021) through the Beat Childhood Cancer Research Consortium.